C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.000
-0.030 (-0.74%)
At close: Aug 21, 2026, 4:00 PM EDT
4.051
+0.051 (1.28%)
After-hours: Aug 21, 2026, 7:55 PM EDT
C4 Therapeutics Employees
C4 Therapeutics had 104 employees as of December 31, 2025. The number of employees decreased by 6 or -5.45% compared to the previous year.
Employees
104
Change (1Y)
-6
Growth (1Y)
-5.45%
Revenue / Employee
$336,913
Profits / Employee
-$975,154
Market Cap
492.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 104 | -6 | -5.45% |
| Dec 31, 2024 | 110 | -35 | -24.14% |
| Dec 31, 2023 | 145 | -1 | -0.68% |
| Dec 31, 2022 | 146 | 25 | 20.66% |
| Dec 31, 2021 | 121 | 22 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| EyePoint | 214 |
| Puma Biotechnology | 179 |
| Kyverna Therapeutics | 149 |
| MapLight Therapeutics | 133 |
| Ocugen | 116 |
| Rezolute | 68 |
| Q32 Bio | 22 |
CCCC News
- 12 days ago - C4 Therapeutics reports Q2 EPS (18c), consensus (23c) - TheFly
- 12 days ago - C4 Therapeutics Earnings release: Q2 2026 - Filings
- 12 days ago - C4 Therapeutics Quarterly report: Q2 2026 - Filings
- 13 days ago - C4 Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - C4 Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - C4 Therapeutics Transcript: KOL event - Transcripts
- 2 months ago - C4 Therapeutics Slides: KOL event - Filings
- 2 months ago - C4 Therapeutics presents further analysis from cemsidomide trial - TheFly